243 related articles for article (PubMed ID: 3426872)
1. Immunisation against cholera with a Ty21a-cholera hybrid.
La Brooy JT; Forrest B; Bartholomeusz C
Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
[No Abstract] [Full Text] [Related]
2. The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.
Dearlove CE; Forrest BD; van den Bosch L; La Brooy JT
J Infect Dis; 1992 Jan; 165(1):182-3. PubMed ID: 1727891
[No Abstract] [Full Text] [Related]
3. Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.
Forrest BD; LaBrooy JT; Attridge SR; Boehm G; Beyer L; Morona R; Shearman DJ; Rowley D
J Infect Dis; 1989 Jan; 159(1):145-6. PubMed ID: 2909633
[No Abstract] [Full Text] [Related]
4. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
Tacket CO; Forrest B; Morona R; Attridge SR; LaBrooy J; Tall BD; Reymann M; Rowley D; Levine MM
Infect Immun; 1990 Jun; 58(6):1620-7. PubMed ID: 1692807
[TBL] [Abstract][Full Text] [Related]
5. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
6. Experience with registered mucosal vaccines.
Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF
Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of vaccination against cholera and typhoid fever.
Germanier R
Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
[No Abstract] [Full Text] [Related]
8. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Cryz SJ; Que JU; Levine MM; Wiedermann G; Kollaritsch H
Infect Immun; 1995 Apr; 63(4):1336-9. PubMed ID: 7890391
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels.
Attridge S
Vaccine; 1991 Dec; 9(12):877-82. PubMed ID: 1725837
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
Forrest BD; LaBrooy JT
Vaccine; 1991 Jul; 9(7):515-20. PubMed ID: 1716810
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for the future: problems and potential solutions from the countries that need them.
Jones T; Badaró R
Braz J Infect Dis; 2000 Jun; 4(3):156-60. PubMed ID: 10934500
[No Abstract] [Full Text] [Related]
12. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.
Faucher JF; Binder R; Missinou MA; Matsiegui PB; Gruss H; Neubauer R; Lell B; Que JU; Miller GB; Kremsner PG
Clin Infect Dis; 2002 Nov; 35(10):1147-54. PubMed ID: 12410473
[TBL] [Abstract][Full Text] [Related]
13. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
[TBL] [Abstract][Full Text] [Related]
14. [Experimental justification for combined subcutaneous immunization against cholera and typhoid fever].
Gapochko KG; Emel'ianova OV; Ziablitsev IF
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):85-9. PubMed ID: 6702364
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
Cryz SJ; Vanprapar N; Thisyakorn U; Olanratmanee T; Losonsky G; Levine MM; Chearskul S
Infect Immun; 1993 Mar; 61(3):1149-51. PubMed ID: 8432597
[TBL] [Abstract][Full Text] [Related]
16. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
Yu X; Ma Q
Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.
Migasena S; Pitisuttitham P; Supanaranond W; Desakorn V; Prayurahong B; Suntharasamai P
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):423-8. PubMed ID: 3217824
[No Abstract] [Full Text] [Related]
18. Construction of a bivalent oral vaccine for prevention of typhoid fever and cholera diarrhea.
Ma QJ; Yu XQ; Liu CX; Zhou JG; Xiong LS; Huang CF
Sci China B; 1990 Jan; 33(1):44-9. PubMed ID: 2190570
[TBL] [Abstract][Full Text] [Related]
19. Intradermal typhoid vaccination by jet injection.
Dimache G
Ann Sclavo Collana Monogr; 1986; 3(1-2):157-63. PubMed ID: 3426873
[No Abstract] [Full Text] [Related]
20. Antibody cross-reactions with lipopolysaccharide from E. coli O157 after cholera vaccination.
Chart H; Rowe B
Lancet; 1993 May; 341(8855):1282. PubMed ID: 8098423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
